Health benefits of docosahexaenoic acid (DHA)

Pharmacological Research

Volumn 40, Issue 3, 1999, Pages 211-225

  Horrocks, Lloyd A ^a,b   Yeo, Young K ^c  

^a Docosa Foods Ltd   (United States)

^b OHIO STATE UNIVERSITY   (United States)

^c Kyungpook National University   (South Korea)

Author keywords

Cardiovascular disease; Development; Docosahexaenoic acid; Nervous system

Indexed keywords

CARBOHYDRATE; DOCOSAHEXAENOIC ACID; FISH OIL; LINOLENIC ACID; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; TRIACYLGLYCEROL;

ADRENOLEUKODYSTROPHY; AGING; ALZHEIMER DISEASE; ARTIFICIAL MILK; ASTHMA; ATTENTION DEFICIT DISORDER; BRAIN FUNCTION; BREAST MILK; CARDIOVASCULAR DISEASE; CYSTIC FIBROSIS; DEPRESSION; DISEASE ASSOCIATION; ESSENTIAL FATTY ACID DEFICIENCY; FAT INTAKE; FATTY ACID METABOLISM; FATTY ACID TRANSPORT; FETAL ALCOHOL SYNDROME; FOOD COMPOSITION; HEALTH; HEART ARRHYTHMIA; HEART INFARCTION; HOSTILITY; HUMAN; INFANT FEEDING; INFLAMMATION; LOW FAT DIET; NON INSULIN DEPENDENT DIABETES MELLITUS; PHENYLKETONURIA; PRIORITY JOURNAL; REVIEW; RHEUMATOID ARTHRITIS; THROMBOSIS; TRIACYLGLYCEROL BLOOD LEVEL; VISUAL ACUITY;

EID: 0344329878     PISSN: 10436618     EISSN: None     Source Type: Journal    
DOI: 10.1006/phrs.1999.0495     Document Type: Article

References (129)

1. Burr GO, Burr MM. A new deficiency disease produced by the rigid exclusion of fat from the diet. J Biol Chem 1929; 82: 345-67.
2. Holman RT. Essential fatty acid deficiency. Prog Chem Fats Other Lipids 1968; 9: 275-348.
3. Neuringer M, Anderson GJ, Connor WE. The essentiality of n-3 fatty acids for the development and function of the retina and brain. Annu Rev Nutr 1988; 8: 517-41.
4. Connor WE, Neuringer M, Reisbick S. Essential fatty acids: the importance of n-3 fatty acids in the retina and brain. Nutr Rev 1992; 50: 21-9.
5. Raper NR, Cronin FJ, Exler J. Omega-3 fatty acid content of the US food supply. J Am Coll Nutr 1992; 11: 304-8.
6. Okuyama H. Recommended LNA/LA ratio for the prevention of chronic, elderly diseases. Abstracts, 88th AOCS Annual Meeting and Expo 1997: 75-75 (Abstract).
7. FAO/WHO. 1993 Report, fats and oils in human nutrition. Rome: Food and Agricultural Organization of the United Nations, 1993: 49-55.
8. The British Nutrition Foundation. Recommendations for intakes of unsaturated fatty acids. In: Anonymous, The Report of the British Nutrition Foundation's Task Force. New York: Chapman and Hall, 1992: 152-63.
9. Haumann BR. Alternative sources for n-3 fatty acids. Inform 1998; 9: 1108-19.
10. Luthria DL, Mohammed BS, Sprecher H. Regulation of the biosynthesis of 4,7,10,13,16,19-docosahexaenoic acid. J Biol Chem 1996; 271: 16020-5.
11. Dyerberg J, Leaf A, Galli C et al. ISSFAL board statement: Recommendations for the essential fatty acid requirement for infant formulas. J Am Coll Nutr 1995; 14: 213-14.
12. Innis SM. The 1993 Borden Award Lecture. Fatty acid requirements of the newborn. Can J Physiol Pharmacol 1994; 72: 1483-92.
13. Anderson GJ. Developmental sensitivity of the brain to dietary n-3 fatty acids. J Lipid Res 1994; 35: 105-11.
14. Ratnayake WMN, Hollywood R. Influence of diet on human milk fatty acid composition. Abstracts, 88th AOCS Annual Meeting and Expo 1997: 96-96 (Abstract).
15. Francois CA, Comor SL, Wander RC, Connor WE. Acute effects of dietary fatty acids on the fatty acids of human milk. Am J Clin Nutr 1998; 67: 301-8.
16. Ikemoto A, Kobayashi T, Watanabe S, Okuyama H. Membrane fatty acid modifications of PC12 cells by arachidonate or docosahexaenoate affect neurite outgrowth but not norepinephrine release. Neurochem Res 1997; 22: 671-8.
17. Green P, Yavin E. Mechanisms of docosahexaenoic acid accretion in the fetal brain. J Neurosci Res 1998; 52: 129-36.
18. Salem N Jr, Wegher B, Mena P, Uauy R. Arachidonic and docosahexaenoic acids are biosynthesized from their 18-carbon precursors in human infants. Proc Natl Acad Sci USA 1996; 93: 49-54.
19. Boehm G, Borte M, Bohles HJ, Muller H, Kohn G, Moro G. Docosahexaenoic and arachidonic acid content of serum and red blood cell membrane phospholipids of preterm infants fed breast milk, standard formula or formula supplemented with n-3 and n-6 long-chain polyunsaturated fatty acids. Eur J Pediatr 1996; 155: 410-16.
20. Lucas A, Morley R, Cole TJ, Lister G, Leeson-Payne C. Breast milk and subsequent intelligence quotient in children born preterm. Lancet 1992; 339: 261-4.
21. Carlson SE, Werkman SH, Peeples JM, Wilson WM. Long-chain fatty acids and early visual and cognitive development of preterm infants. Eur J Clin Nutr 1994; 48(Suppl 2): S27-30.
22. Crawford MA, Costeloe K, Ghebremeskel K, Phylactos A, Skirvin L, Stacey F. Are deficits of arachidonic and docosahexaenoic acids responsible for the neural and vascular complications of preterm babies? Am J Clin Nutr 1997; 66: 1032S-41S.
23. Neuringer M. Cerebral cortex docosahexaenoic acid is lower in formula-fed than in breast-fed infants. Nutr Rev 1993; 51: 238-41.
24. Makrides M, Neumann MA, Gibson RA. Is dietary docosahexaenoic acid essential for term infants? Lipids 1996; 31: 115-19.
25. Gibson RA, Neumann MA, Makrides M. Effect of dietary docosahexaenoic acid on brain composition and neural function in term infants. Lipids 1996; 31(Suppl): S177-181.
26. Agostoni C, Trojan S, Bellu R, Riva E, Bruzzese MG, Giovannini M. Developmental quotient at 24 months and fatty acid composition of diet in early infancy: A follow up study. Arch Dis Child 1997; 76: 421-4.
27. Heinonen EH, Savijarvi M, Kotila M, Hajba A, Scheinin M. Effects of monoamine oxidase inhibition by selegiline on concentrations of noradrenaline and monoamine metabolites in CSF of patients with Alzheimer's disease. J Neural Transm Park Dis Dement Sect 1993; 5: 193-202.
28. Makrides M, Neumann MA, Byard RW, Simmer K, Gibson RA. Fatty acid composition of brain, retina, and erythrocytes in breast- and formula-fed infants. Am J Clin Nutr 1994; 60: 189-94.
29. Farquharson J, Jamieson EC, Abbasi KA, Patrick WJA, Logan RW, Cockburn F. Effect of diet on the fatty acid composition of the major phospholipids of infant cerebral cortex. Arch Dis Child 1995; 72: 198-203.
30. Connor WE, Neuringer M, Lin DS. Dietary effects on brain fatty acid composition: the reversibility of n-3 fatty acid deficiency and turnover of docosahexaenoic acid in the brain, erythrocytes, and plasma of rhesus monkeys. J Lipid Res 1990; 31: 237-47.
31. Makrides M, Simmer K, Goggin M, Gibson RA. Erythrocyte docosahexaenoic acid correlates with the visual response of healthy, term infants. Pediatr Res 1993; 33: 425-7.
32. Streissguth P, Barr HM, Sampson PD, Darby BL, Martin DC. IQ at age 4 in relation to maternal alcohol use and smoking during pregnancy. Dev Psychobiol 1989; 25: 3-11.
33. Jones KL, Smith DW. Recognition of the fetal alcohol syndrome in early infancy. Lancet 1973; 2: 999-1001.
34. Jones KL, Smith DW, Ulleland CN, Streissguth P. Pattern of malformation in offspring of chronic alcoholic mothers. Lancet 1973; 1: 1267-71.
35. Henderson GI, Patwardhan RV, Hoyumpa AM, Schenker S. Fetal alcohol syndrome: overview of pathogenesis. Neurobehav Toxicol Teratol 1981; 3: 73-80.
36. Flores-Huerta S, Hernandez-Montes H, Argote RM, Villalpando S. Effects of alcohol consumption during pregnancy and lactation on the outcome and postnatal growth of the offspring. Ann Nutr Metab 1992; 36: 121-8.
37. Burdge GC, Wright SM, Warner JO, Postle AD. Fetal brain and liver phospholipid fatty acid composition in a guinea pig model of fetal alcohol syndrome: Effect of maternal supplementation with tuna oil. J Nutr Biochem 1997; 8: 438-44.
38. Stordy BJ. Benefit of docosahexaenoic acid supplements to dark adaptation in dyslexies [letter; comment]. Lancet 1995; 346: 385-85.
39. Stevens LJ, Zentall SS, Deck JL et al. Essential fatty acid metabolism in boys with attention-deficit hyperactivity disorder. Am J Clin Nutr 1995; 62: 761-8.
40. Martinez M, Vazquez E. MRI evidence that docosahexaenoic acid ethyl ester improves myelination in generalized peroxisomal disorders. Neurology 1998; 51: 26-32.
41. Roulet M, Frascarolo P, Rappaz I, Pilet M. Essential fatty acid deficiency in well nourished young cystic fibrosis patients. Eur J Pediatr 1997; 156: 952-6.
42. Alvarez J, Freedman S. Administration of docosahexaenoic acid (DHA) reverses the pathological manifestations of cystic fibrosis in CFTR (-/-) mice. Pediatr Pulmonol 1998; Suppl 17: 274-274 (Abstract).
43. Sanjurjo P, Ruiz JI, Montejo M. Inborn errors of metabolism with a protein-restricted diet: effect on polyunsaturated fatty acids. J Inherit Metab Dis 1997; 20: 783-9.
44. Yoshida S, Sato A, Okuyama H. Pathophysiological effects of dietary essential fatty acid balance on neural systems. Jpn J Pharmacol 1998; 77: 11-22.
45. Okaniwa Y, Yuasa S, Yamamoto N et al. A high linoleate and a high α-linolenate diet induced changes in learning behavior of rats. Effects of a shift in diets and reversal of training stimuli. Biol Pharm Bull 1996; 19: 536-40.
46. Yamamoto N, Okaniwa Y, Mori S, Nomura M, Okuyama H. Effects of a high-linoleate and a high-alpha-linolenate diet on the learning ability of aged rats. Evidence against an autoxidation-related lipid peroxide theory of aging. J Gerontol 1991; 46: B17-22.
47. Yoshida S, Yasuda A, Kawazato H et al. Synaptic vesicle ultrastructural changes in the rat hippocampus induced by a combination of alphalinolenate deficiency and a learning task. J Neurochem 1997; 68: 1261-8.
48. Yoshida S, Miyazaki M, Takeshita M et al. Functional changes of rat brain microsomal membrane surface after learning task depending on dietary fatty acids. J Neurochem 1997; 68: 1269-77.
49. Farquharson J, Jamieson EC, Logan RW, Patrick WJA, Howatson AG, Cockburn F. Age- and dietary-related distributions of hepatic arachidonic and docosahexaenoic acid in early infancy. Pediatr Res 1995; 38: 361-5.
50. Innis SM, Nelson CM, Lwanga D, Rioux FM, Waslen P. Feeding formula without arachidonic acid and docosahexaenoic acid has no effect on preferential looking acuity or recognition memory in healthy fullterm infants at 9 mo of age. Am J Clin Nutr 1996; 64: 40-6.
51. Bazan NG, Rodriguez de Turco EB, Gordon WC. Pathways for the uptake and conservation of docosahexaenoic acid in photoreceptors and synapses: biochemical and autoradiographic studies. Can J Physiol Pharmacol 1993; 71: 690-8.
52. Bourre JME, Dumont OL, Piciotti MJ, Clement ME, Durand GA. Comparison of vegetable and fish oil in the provision of N-3 polyunsaturated fatty acids for nervous tissue and selected organs. J Nutr Biochem 1997; 8: 472-8.
53. Gould E, Tanapat P, McEwen BS, Flögge G, Fuchs E. Proliferation of granule cell precursors in the dentate gyrus of adult monkeys is diminished by stress. Proc Natl Acad Sci USA 1998; 95: 3168-71.
54. Minami M, Kimura S, Endo T et al. Dietary docosahexaenoic acid increases cerebral acetylcholine levels and improves passive avoidance performance in stroke-prone spontaneously hypertensive rats. Pharmacol Biochem Behav 1997; 58: 1123-9.
55. Hibbeln JR, Salem N Jr. Dietary polyunsaturated fatty acids and depression: When cholesterol does not satisfy. Am J Clin Nutr 1995; 62: 1-9.
56. Adams PB, Lawson S, Sanigorski A, Sinclair AJ. Arachidonic acid to eicosapentaenoic acid ratio in blood correlates positively with clinical symptoms of depression. Lipids 1996; 31 Suppl: S157-61.
57. Edwards R, Peet M, Shay J, Horrobin D. Omega-3 polyunsaturated fatty acid levels in the diet and in red blood cell membranes of depressed patients. J Affect Disord 1998; 48: 149-55.
58. Weidner G, Connor SL, Hollis JF, Connor WE. Improvements in hostility and depression in relation to dietary change and cholesterol lowering. Ann Intern Med 1992; 117: 820-3.
59. Hibbeln JR. Fish consumption and major depression [letter]. Lancet 1998; 351: 1213.
60. Virkkunen ME, Horrobin DF, Jenkins DK, Manku MS. Plasma phospholipids, essential fatty acids and prostaglandins in alcoholic, habitually violent and impulsive offenders. Biol Psychiatry 1987; 22: 1087-96.
61. Leaf A, Weber PC. A new era for science in nutrition. Am J Clin Nutr 1987; 45: 1048-53.
62. Kalmijn S, Feskens EJM, Launer LJ, Kromhout D. Polyunsaturated fatty acids, antioxidants, and cognitive function in very old men. Am J Epidemiol 1997; 145: 33-41.
63. Grant WB. Dietary links to Alzheimer's disease. Alz Dis Rev 1997; 2: 42-55.
64. Stewart WF, Kawas C, Corrada M, Metter EJ. Risk of Alzheimer's disease and duration of NSAID use. Neurology 1997; 48: 626-32.
65. Münch G, Thome J, Foley P, Schinzel R, Riederer P. Advanced glycation endproducts in ageing and Alzheimer's disease. Brain Res Brain Res Rev 1997; 23: 134-43.
66. Yehuda S, Rabinovitz S, Mostofsky DI, Huberman M, Sredni B. Essential fatty acid preparation improves biochemical and cognitive functions in experimental allergic encephalomyelitis rats. Eur J Pharmacol 1997; 328: 23-9.
67. Yehuda S, Rabinovitz S, Carasso RL, Mostofsky DI. Essential fatty acids preparation (SR-3) improves Alzheimer's patients quality of life. Int J Neurosci 1996; 87: 141-9.
68. Anderson GJ, Connor WE. On the demonstration of omega-3 essential fatty-acid deficiency in humans [editorial]. Am J Clin Nutr 1989; 49: 585-7.
69. Heird WC, Prager TC, Anderson RE. Docosahexaenoic acid and the development and function of the infant retina. Curr Opin Lipidol 1997; 8: 12-16.
70. Reece MS, McGregor JA, Allen KGD, Harris MA. Maternal and perinatal long-chain fatty acids: Possible roles in preterm birth. Am J Obstet Gynecol 1997; 176: 907-14.
71. 2, and alpha-fetoprotein concentrations at the human feto-maternal interface. J Lipid Res 1997; 38: 276-86.
72. Okada M, Amamoto T, Tomonaga M et al. The chronic administration of docosahexaenoic acid reduces the spatial cognitive deficit following transient forebrain ischemia in rats. Neuroscience 1996; 71: 17-25.
73. 2 during the hydrolysis of diacyl and alkenylacylglycerophosphoethanolamine. Biochim Biophys Acta Lipids Lipid Metab 1994; 1212: 211-16.
74. 2 in tumor necrosis factor-induced apoptosis. Proc Natl Acad Sci USA 1997; 94: 5073-7.
75. Kishida E, Yano M, Kasahara M, Masuzawa Y. Distinctive inhibitory activity of docosahexaenoic acid against sphingosine-induced apoptosis. Biochim Biophys Acta Lipids Lipid Metab 1998; 1391: 401-08.
76. Nair SSD, Leitch JW, Falconer J, Garg ML. Prevention of cardiac arrhythmia by dietary (n-3) polyunsaturated fatty acids and their mechanism of action. J Nutr 1997; 127: 383-93.
77. Garg A, Bantle JP, Henry RR et al. Effects of varying carbohydrate content of diet in patients with non-insulin-dependent diabetes mellitus [see comments]. J Am Med Assoc 1994; 271: 1421-8.
78. Siscovick DS, Raghunathan TE, King I et al. Dietary intake and cell membrane levels of long-chain n-3 polyunsaturated fatty acids and the risk of primary cardiac arrest. J Am Med Assoc 1995; 274: 1363-7.
79. Daviglus ML, Stamler J, Orencia AJ et al. Fish consumption and the 30-year risk of fatal myocardial infarction. New Eng J Med 1997; 336: 1046-53.
80. Burr ML, Fehily AM, Gilbert JF et al. Effects of changes in fat, fish, and fibre intakes on death and myocardial reinfarction: diet and reinfarction trial (DART). Lancet 1989; 2: 757-61.
81. Billman GE, Kang JX, Leaf A. Prevention of ischemia-induced cardiac sudden death by n-3 polyunsaturated fatty acids in dogs. Lipids 1997; 32: 1161-8.
82. Kang JX, Leaf A. The cardiac antiarrhythmic effects of polyunsaturated fatty acid. Lipids 1996; 31 Suppl: S41-4.
83. Suarez A, Ramirez MDC, Faus MJ, Gil A. Dietary long-chain polyunsaturated fatty acids influence tissue fatty acid composition in rats at weaning. J Nutr 1996; 126: 887-97.
84. Albert CM, Hennekens CH, O'Donnell CJ et al. Fish consumption and risk of sudden cardiac death [see comments]. J Am Med Assoc 1998; 279: 23-8.
85. Hu FB, Stampfer MJ, Manson JE et al. Dietary fat intake and the risk of coronary heart disease in women [see comments]. N Engl J Med 1997; 337: 1491-9.
86. Ascherio A, Willett WC. Health effects of trans fatty acids. Am J Clin Nutr 1997; 66: 1006S-10S.
87. McLennan PL, Howe P, Abeywardena M et al. The cardiovascular protective role of docosahexaenoic acid. Eur J Pharmacol 1996; 300: 83-9.
88. Reithmann C, Scheininger C, Bulgan T, Werdan K. Exposure to the n-3 polyunsaturated fatty acid docosahexaenoic acid impairs alpha 1-adrenoceptor-mediated contractile responses and inositol phosphate formation in rat cardiomyocytes. Naunyn Schmiedebergs Arch Pharmacol 1996; 354: 109-19.
89. Eritsland J, Arnesen H, Gronseth K, Fjeld NB, Abdelnoor M. Effect of dietary supplementation with n-3 fatty acids on coronary artery bypass graft patency. Am J Cardiol 1996; 77: 31-6.
90. Jeppesen J, Hein HO, Suadicani P, Gyntelberg F. Relation of high TG low HDL cholesterol and LDL cholesterol to the incidence of ischemic heart disease - An 8-year follow-up in the Copenhagen Male Study. Arterioscler Thromb Vase Biol 1997; 17: 1114-20.
91. Skuladottir GV, Gudmundsdottir S, Olafsson GB, Sigurdsson SB, Sigfusson N, Axelsson J. Plasma fatty acids and lipids in two separate, but genetically comparable, Icelandic populations. Lipids 1995; 30: 649-55.
92. Orencia AJ, Daviglus ML, Dyer AR, Shekelle RB, Stamler J. Fish consumption and stroke in men. 30-year findings of the Chicago Western Electric Study. Stroke 1996; 27: 204-9.
93. Terano T, Shiina T, Yamamoto K et al. Eicosapentaenoic acid and docosahexaenoic acid inhibit DNA synthesis through inhibiting cdk2 kinase in vascular smooth muscle cells. Ann NY Acad Sci 1997; 811: 369-77.
94. Shiina T, Terano T, Saito J, Tamura Y, Yoshida S. Eicosapentaenoic acid and docosahexaenoic acid suppress the proliferation of vascular smooth muscle cells. Atherosclerosis 1993; 104: 95-103.
95. Asano M, Nakajima T, Iwasawa Y et al. Inhibitory effects of omega-3 polyunsaturated fatty acids on receptor-mediated non-selective cation currents in rat A7r5 vascular smooth muscle cells. Br J Pharmacol 1997; 120: 1367-75.
96. + channels: subunit selective antagonism by zinc. Neuropharmacology 1996; 35: 969-82.
97. Freese R, Mutanen M. Alpha-linolenic acid and marine long-chain n-3 fatty acids differ only slightly in their effects on hemostatic factors in healthy subjects. Am J Clin Nutr 1997; 66: 591-8.
98. Nieuwenhuys CMA, Hornstra G. The effects of purified eicosapentaenoic and docosahexaenoic acids on arterial thrombosis tendency and platelet function in rats. Biochim Biophys Acta Lipids Lipid Metab 1998; 1390: 313-22.
99. Layne KS, Goh YK, Jumpsen JA, Ryan EA, Chow P, Clandinin MT. Normal subjects consuming physiological levels of 18:3(n-3) and 20:5(n-3) from flaxseed or fish oils have characteristic differences in plasma lipid and lipoprotein fatty acid levels. J Nutr 1996; 126: 2130-40.
100. Davidson MH, Maki KC, Kalkowski J, Schaefer EJ, Torri SA, Drennan KB. Effects of docosahexaenoic acid on serum lipoproteins in patients with combined hyperlipidemia: A randomized, double-blind, placebo-controlled trial. J Am Coll Nutr 1997; 16: 236-43.
101. De Caterina R, Cybulsky MI, Clinton SK, Gimbrone MA Jr, Libby P. The omega-3 fatty acid docosahexaenoate reduces cytokine-induced expression of proatherogenic and proinflammatory proteins in human endothelial cells. Arterioscler Thromb 1994; 14: 1829-36.
102. Hirai A, Terano T, Makuta H et al. Effect of oral administration of highly purified eicosapentaenoic acid and docosahexaenoic acid on platelet function and serum lipids in hyperlipidemic patients. Adv Prostagland Thromb Leuk Res 1989; 19: 627-30.
103. Benistant C, Achard F, Marcelon G, Lagarde M. Platelet inhibitory functions of aortic endothelial cells. Effects of eicosapentaenoic and docosahexaenoic acids. Atherosclerosis 1993; 104: 27-35.
104. Grimsgaard S, Bonaa KH, Hansen JB, Nordoy A. Highly purified eicosapentaenoic acid and docosahexaenoic acid in humans have similar triacylglycerol-lowering effects but divergent effects on serum fatty acids. Am J Clin Nutr 1997; 66: 649-59.
105. Hansen JB, Grimsgaard S, Nilsen H, Nordoy A, Bonaa KH. Effects of highly purified eicosapentaenoic acid and docosahexaenoic acid on fatty acid absorption, incorporation into serum phospholipids and postprandial triglyceridemia. Lipids 1998; 33: 131-8.
106. Conquer JA, Holub BJ. Dietary docosahexaenoic acid as a source of eicosapentaenoic acid in vegetarians and omnivores. Lipids 1997; 32: 341-5.
107. Petroni A, Blasevich M, Salami M, Papini N, Montedoro GF, Galli C. Inhibition of platelet aggregation and eicosanoid production by phenolic components of olive oil. Thromb Res 1995; 78: 151-60.
108. Weber N, Mukherjee KD. Steep rise of docosahexaenoic acid in phosphatidylethanolamines of heart and liver of rats fed native olive oil or rapeseed oil. Nutr Res 1998; 18: 851-61.
109. Navarro NW, Periago JL, Pita ML, Hortelano P. The n-3 polyunsaturated fatty acid levels in rat tissue lipids increase in response to dietary olive oil relative to sunflower oil. Lipids 1994; 29: 845-9.
110. Periago JL, Suarez MD, Pita ML. Effect of dietary olive oil, corn oil and medium-chain triglycerides on the lipid composition of rat red blood cell membranes. J Nutr 1990; 120: 986-94.
111. Ghosh J, Myers CE. Arachidonic acid stimulates prostate cancer cell growth: Critical role of 5-lipoxygenase. Biochem Biophys Res Commun 1997; 235: 418-23.
112. Rose DP, Connolly JM, Rayburn J, Coleman M. Influence of diets containing eicosapentaenoic or docosahexaenoic acid on growth and metastasis of breast cancer cells in nude mice. J Natl Cancer Inst 1995; 87: 587-92.
113. Tang DG, Guan KL, Li L et al. Suppression of W256 carcinosarcoma cell apoptosis by arachidonic acid and other polyunsaturated fatty acids. Int J Cancer 1997; 72: 1078-87.
114. Parodi PW. Cows' milk fat components as potential anticarcinogenic agents. J Nutr 1997; 127: 1055-60.
115. Ip C. Review of the effects of trans fatty acids, oleic acid, n-3 polyunsaturated fatty acids, and conjugated linoleic acid on mammary carcinogenesis in animals. Am J Clin Nutr 1997; 66: 1523S-9S.
116. Atkinson TG, Barker HJ, Meckling-Gill KA. Incorporation of long-chain n-3 fatty acids in tissues and enhanced bone marrow cellularity with docosahexaenoic acid feeding in post-weanling Fischer 344 rats. Lipids 1997; 32: 293-302.
117. Nakamura N, Hamazaki T, Kobayashi M, Yazawa K. The effect of oral administration of eicosapentaenoic and docosahexaenoic acids on acute inflammation and fatty acid composition in rats. J Nutr Sci Vitaminol (Tokyo) 1994; 40: 161-70.
118. Paul KP, Leichsenring M, Pfisterer M et al. Influence of n-6 and n-3 polyunsaturated fatty acids on the resistance to experimental tuberculosis. Metabolism 1997; 46: 619-24.
119. American Academy of Allergy, Asthma and Immunology. Asthma. http://www.aaaai.org. 1997.
120. Hodge L, Salome CG, Peat JK, Haby MM, Xuan W, Woolcock AJ. Consumption of oily fish and childhood asthma risk. Med J Aust 1996; 164: 137-40.
121. Hodge L, Salome CM, Hughes JM et al. Effect of dietary intake of omega-3 and omega-6 fatty acids on severity of asthma in children. Eur Respir J 1998; 11: 361-5.
122. Dahlen SE, Bjork J, Hedquist P et al. Leukotrienes promote plasma leakage and leukocyte adhesion in post-capillary vessels: in vivo effects with relevance to the acute inflammatory response. Proc Nad Acad Sci USA 1981; 78: 3887-91.
123. Broughton KS, Johnson CS, Pace BK, Liebman M, Kleppinger KM. Reduced asthma symptoms with n-3 fatty acid ingestion are related to 5-series leukotriene production. Am J Clin Nutr 1997; 65: 1011-17.
124. Knapp HR. Omega-3 fatty acids in respiratory diseases: A review. J Am Coll Nutr 1995; 14: 18-23.
125. Turek JJ, Schoenlein IA, Watkins BA, Van Alstine WG, Clark LK, Knox K. Dietary polyunsaturated fatty acids modulate responses of pigs to Mycoplasma hyopneumoniae infection. J Nutr 1996; 126: 1541-8.
126. Halvorsen DS, Hansen JB, Grimsgaard S, Bonaa KH, Kierulf P, Nordoy A. The effect of highly purified eicosapentaenoic and docosahexaenoic acids on monocyte phagocytosis in man. Lipids 1997; 32: 935-42.
127. Yamada N, Kobatake Y, Ikegami S et al. Changes in blood coagulation, platelet aggregation, and lipid metabolism in rats given lipids containing docosahexaenoic acid. Biosci Biotechnol Biochem 1997; 61: 1454-8.
128. James DG. Fish as food: present utilisation and future prospects. Omega-3 News 1994; 9: 1-4.
129. Sargent JR. Fish oils and human diet. Br J Nutr 1997; 78: S5-13.